期刊文献+

“超级细菌”再认识 被引量:4

Get to Know Supergerms Better
原文传递
导出
摘要 "超级细菌"是含有新德里金属β内酰胺酶(NDM-1)基因的多重耐药菌的统称。自2009年7月首次报道后,先后在印度、巴基斯坦、英国、美国、日本及中国等均有报道。初步研究认为该菌对现存的多种抗生素耐药,应对措施不全,对公众健康具有潜在威胁;合理使用抗生素是预防"超级细菌"感染的有效方法。 Supergerms are multiple drug-resistance bacteria which contain the New Delhi metallo-β-lactamase gene. Since reported in July-2009,NDM-1 has been found in India,Pakistan,UK,USA,Japan and China. The preliminary research shows that it has resistance to most antibiotics. At present,mankind can not properly deal with NDM-1. It may be a great potential public health problem. The most important and efficient precautions is reasonable use of antibiotics.
作者 程延安 李梅
出处 《中国皮肤性病学杂志》 CAS 北大核心 2010年第12期1081-1083,共3页 The Chinese Journal of Dermatovenereology
关键词 超级细菌 新德里金属β内酰胺酶(NDM-1) 抗生素 耐药性 Supergerms New Delhi metallo-β-lactamase Antibiotics Drug tolerance
  • 相关文献

参考文献7

  • 1Kumarasamy KK,Toleman MA,Walsh TR,et al.Emergence of a new antibiotic resistance mechanism in India,Pakistan,and the UK:a molecular,biological,and epidemiological study[J].Lancet Infect Dis,2010,10(9):597-602.
  • 2Yong D,Toleman MA,Giske CG,et al.Characterization of a new metallo-beta-lactamase gene,bla(NDM-1),and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India[J].Antimicrobial Agents Chemotherapy,2009,53(12):5046-5054.
  • 3Deshpande P,Bedrigues C,Shetty A,et al.New Delhi Metallo-blactamase(NDM-1)in Enterobacteriaceae:treatment options with carbapenems compromised[J].J Assoc Physicians India,2010,58:147-149.
  • 4Multi-resistant hospital bacteria linked to India and Pakistan[J].Health Protection Report,2009,3(26):3.
  • 5Rolain JM,Parola P,Comaglia G.New delhi metallo-beta-lactamase(NDM-1):towards a new pandemia.Clinical Microbiology and Infection[J].Accepted Article,2010,10(1111):1469-0691.
  • 6Taubes G.The bacteria fight back[J].Science,2008,321(5887):356-361.
  • 7中华人民共和国卫生部.专家解读耐药细菌知识[EB/OL].(2010-10-14)[2010-10-25].http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohbgt/s10329/201010/49312.htm.

同被引文献42

  • 1赵健,李野.遏制抗生素滥用是药品监管的重要责任[J].中国药业,2004,13(12):4-5. 被引量:6
  • 2马丽萍,郭亚萍,蔡德芳,王存仙,杨寿林.护士奖金分配改革的做法与体会[J].护理管理杂志,2005,5(4):44-45. 被引量:14
  • 3丁克颖,席韵,范烨.532例医院感染病例的回顾性调查[J].中国公共卫生,2004,20(12):1503-1504. 被引量:6
  • 4汪复.如何应对“超级细菌”的挑战[J].中国感染与化疗杂志,2010,10(6):401-402. 被引量:7
  • 5Jones R N.Microbiological features of vancomycin in the 21 st century:minimum inhibitory concentration creep,bactericidal/static activity,and applied breakpoints to predict clinical outcomes or detect resistant strains[J].Clin Infect Dis,2006,42(1):S13-S24.
  • 6Klein E,Smith D L,Laxminarayan R. Hospitalizations and deaths caused by methicillin resistant Staphylococcus aureus,United States[J].Emerg In fect Dis,2007,13(5):1840-1846.
  • 7Wemer G,Coque T M,Hammerum AM,et al.Emergence and spread of vancomycin resistance among enterococcus in Europe[J].Eur osurveillance,2008,13 (47):1-1 1.
  • 8Xiao Y H,Wang J,Li Y.Bacterial resistance surveillance in China:a report from Mohnarin 2004-2005[J].Eur J Clin Microbiol Infect Dis,2008,27 (3):697-709.
  • 9Yigit H,Queenan A M,Anderson G J,et al.Novel carbapenemhydrolyzing beta-lactamase,KPC-1,froma carbapenem-resistant strain of Klebsiella pneumoniae[J].Antimicrob Agents Chemother,2001,45(4):1151-1161.
  • 10Wei Z Q,Du X X,Yu Y S,et al.Plasmid-mediated KPC-2 in a klebsiella pneumoniae isolate from China[J].Antimicrob Agents Chemother,2007,51 (2):763-765.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部